Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma

BACKGROUND & AIMS: We evaluated the relationship between the early clinical response after 2 weeks of sorafenib therapy and the outcomes and anti-tumor response in patients with advanced hepatocellular carcinoma. METHODS: Fifty-seven patients who had intrahepatic hypervascular hepatocellular car...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzuya, Teiji, Ishigami, Masatoshi, Ishizu, Yoji, Honda, Takashi, Hayashi, Kazuhiko, Katano, Yoshiaki, Hirooka, Yoshiki, Ishikawa, Tetsuya, Nakano, Isao, Goto, Hidemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589320/
https://www.ncbi.nlm.nih.gov/pubmed/26421430
http://dx.doi.org/10.1371/journal.pone.0138776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589320/
https://www.ncbi.nlm.nih.gov/pubmed/26421430
http://dx.doi.org/10.1371/journal.pone.0138776

Ejemplares similares